COVID-19

Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.

The study, done on a mild-mannered relative of the virus that causes COVID-19, paves the way for seeing more clearly how spike proteins initiate infections, with an eye to preventing and treating them.

The lab’s X-ray laser recently joined other facilities in making remote science possible from any corner of the world, a trend that will likely continue into the future.

Images reveal how some antibodies may block SARS-CoV-2 infection.

No human cell can function without these tiny machines, which cause disease when they go haywire and offer potential targets for therapeutic drugs.

They found that gently heating N95 masks in high relative humidity could inactivate SARS-CoV-2 virus trapped within the masks, without degrading the masks’ performance.

University of Alberta researchers worked with SLAC X-ray scientists to explore the potential of a feline coronavirus drug that may be effective against SARS-CoV-2.

The technology could save the lives of COVID-19 patients when more advanced ventilators are too expensive or not available.

Scientists are deploying this state-of-the-art X-ray crystallography facility to study biological molecules related to the COVID-19 pandemic.